Protagonist Therapeutics (PTGX) PT Raised to $121 at Jefferies

BTIG Reiterates Buy Rating on Harrow Health (HROW) ahead of presentations

BTIG Reiterates Buy Rating on Harrow Health (HROW) ahead of presentations

William Blair Reiterates Market Perform Rating on Carlisle (CSL) amid roofing price hikes

Evercore ISI still In Line on Progressive Corp. (PGR) despite 'solid print'

Morgan Stanley stays Overweight on Johnson & Johnson (JNJ) following 'expected positive' Ico approval

Jefferies Reiterates Buy Rating on Macy's (M): 'encouraged by Q1 comp guide'

Raymond James stays Strong Buy on Electrovaya Inc. (ELVA): 'multiple avenues for accelerated growth'

Jefferies stays Buy rated on InterDigital Inc. (IDCC): 'more bullish on path to $1B of ARR'

GDS Holdings (GDS) PT Raised to $67.50 at Macquarie as Chinese hyperscalers step up CapEx commitments

Morgan Stanley stays Overweight on Autodesk (ADSK) following February billings index

Leerink Partners Reiterates Outperform on BrightSpring Health (BTSG) after Investor Day

Truist Securities models $730M peak revenue for Protagonist Therapeutics (PTGX) in Icotyde royalties

CytomX Therapeutics (CTMX) PT Raised to $16 at Jefferies: 'buying opportunity here'

Compagnie Financiere Richemont SA (CFR:SW) (CFRUY) PT Lowered to CHF200 at TD Cowen

Tenaris S.A. (TS) PT Raised to $60 at TD Cowen

TD Cowen on SAP AG (SAP): 'Europe Best Ideas: Well Positioned In The AI Era'

TD Cowen: 'AstraZeneca's (AZN) history of innovation offers opportunity for upside'

RBC Capital on Constellation Brands (STZ): 'We would view any margin reset related pull back as an attractive opportunity'

Craig-Hallum stays Buy rated on comScore (SCOR) after 'bounce-back quarter,' more strategic actions possible

UBS Reiterates Buy Rating on Eli Lilly (LLY) Following Strong Q4, Upside Guidance

BlackLine (BL) PT Lowered to $44 at BMO Capital

Craig-Hallum lowers PT on Xtant Medical (XTNT) on expected EBITDA margin compression

Oklo (OKLO) PT Lowered to $71 at Craig-Hallum on increased OpEx and CapEx

Citi Trends (CTRN) PT Raised to $67 at Craig-Hallum

Planet Fitness (PLNT) PT Lowered to $120 at UBS as 'Latest Data Doesn't Look Great'

BMO Capital: 'HealthEquity, Inc (HQY) Raises FY27 Outlook on Strong Fundamentals'

William Blair on Lantheus Holdings (LNTH) following PDUFA date extended: 'optimistic' co will receive approval

Spotify (SPOT) PT Lowered to $650 at Evercore ISI

RBC Capital Downgrades Starbucks (SBUX) to Sector Perform

Jefferies on The Trade Desk (TTD): 'incrementally cautious' as Publicis pulls DSP recommendation

Jefferies on Lululemon (LULU) earnings: EPS guide suggests challenges persist

WaterBridge Infrastructure (WBI) PT Raised to $26 at Goldman Sachs

BofA on Freshpet (FRPT): HQ visit highlights ‘right to win’ strategy

BTIG on Aldeyra Therapeutics (ALDX): CRL 'hard to defend,' path to clarity within 90 days

BTIG Upgrades LENSAR Inc. (LNSR) to Buy

RBC Negative on The Trade Desk (TTD) News

Morgan Stanley on Top Pick GDS Holdings (GDS): 'We think current valuation of ~11x 2026e China EV/EBITDA looks attractive'

Academy Sports (ASO) PT Lowered to $61 at Jefferies, but 'believe the stock is poised to move higher'

Lantheus Holdings (LNTH) PT Raised to $110 at Jefferies

TD Cowen on Freshpet (FRPT): 'New Competing Kirkland Product Poses A Threat'

Tencent Music Entertainment Group (TME) PT Lowered to $10.70 at Macquarie

BofA on Amazon.com (AMZN): 'We remain constructive on continued delivery efficiency improvements'

Evercore ISI on MasterCard (MA) acquisition: 'both offensive and defensive' play

Evercore ISI on Zillow Group (ZG): Preview 'should strengthen advantage in demand and monetization'

BofA on Atour Lifestyle Holdings (ATAT): 'can continue to achieve decent earnings growth'

BofA on Atour Lifestyle Holdings (ATAT): 'can continue to achieve decent earnings growth'

Jefferies on The Simply Goods Group (SMPL): 'we see an asset with strategic value at a healthy discount to fair value'

America's Car-Mart (CRMT) PT Lowered to $14 at Jefferies

BofA on Steel Dynamics (STLD): 'free cash flow (FCF) should inflect meaningfully'

Raymond James on Lennar (LEN): 'Turnaround Timeline Still a Work in Progress'

UBS Starts Minerals 260 Ltd (MI6:AU) at Buy

Evercore ISI Removes Amphenol (APH) from TAP Outperform List

Samsung Electronics Co Ltd. (005930:KS) (SSNLF) PT Raised to KRW320,000 at Nomura/Instinet

Goldman Sachs Positive on Zillow Group (ZG) Launch of Zillow Preview

Leerink Partners on Cencora Inc (COR): stock expected down on CFO retirement, confident in momentum

BofA Securities stays Neutral on Cencora Inc (COR) amid guidance reiteration, CFO departure

Tencent Music Entertainment Group (TME) PT Lowered to $23 at Jefferies

TD Cowen on MasterCard (MA): BVNK deal gives 'clear answer' to MA stablecoin plan questions

Wolfe Research on MasterCard's (MA) BVNK acquisition: 'unsurprising' but positive, MA to benefit from stablecoin infra

Craig-Hallum stays Buy on Green Dot (GDOT): 'opportunity' as current stock indicates 0.68x TBV multiple

Babcock & Wilcox Enterprises (BW) PT Raised to $19 at Craig-Hallum

PlayStudios (MYPS) PT Lowered to $1 at Craig-Hallum: risk/reward 'skews' positive despite more restructuring

Five Below (FIVE) PT Raised to $246 at Craig-Hallum: set to deliver 'another extraordinary print'

Morgan Stanley on Atour Lifestyle Holdings (ATAT): 'Growth Intact'

Semtech Corp. (SMTC) PT Raised to $105 at Craig-Hallum as data center revs expected to accelerate

BofA Securities reiterates Buy on Uber Inc. (UBER): supply outlook better amid Nvidia L4, more OEM suppliers

Evercore ISI: 'COCO scanner data sales were up +51.1% in the W/E 3/8, accelerating vs. +35.8% QTD trends'

RBC Capital on Bausch & Lomb Corp. (BLCO): 'We view the delay in anticipated competition in the US Rx DED market as neutral to slightly positive'

RBC: 'We estimate ZG's initial set of partners represents listings volume roughly 60-80% higher than Compass'

Bitcoin Depot (BTM) PT Lowered to $13 at Noble Capital

Jefferies on Steel Dynamics (STLD): 'Earnings Guide Is Lower than Anticipated'

Diamondback Energy (FANG) PT Raised to $240 at Raymond James

Evercore ISI stays Outperform on Cencora Inc (COR): 'Optimistic' despite CFO change

Morgan Stanley on Chime Financial (CHYM): 'Tax refunds increase more modest than expected'

Itau BBA on Nu Holdings (Nubank) (NU): 'suggest investors add on weakness'

Semtech Corp. (SMTC) PT Raised to $110 at Oppenheimer: 'Emergent AI story on track'

SM Energy (SM) PT Lowered to $30 at TD Cowen

Devon Energy (DVN) PT Raised to $50 at TD Cowen

BofA Securities stays Buy on SharkNinja (SN) as Nielsen data shows strong sell-through

Range Resources (RRC) PT Raised to $45 at TD Cowen

TD Cowen on Bio-Techne Corp. (TECH): 'Sell-Off Looks Overdone, We'd Be Buyers on Today's Weakness'

TD Cowen on Autoliv (ALV): 'Europe Best Ideas: Unique Defensive Qualities & Steady LT Growth'

Morgan Stanley stays Overweight on Celsius Holdings (CELH), estimates Alani growth in mid-80%s

Morgan Stanley on Pfizer (PFE): Atirmo Ph2 data an 'incremental positive'

Morgan Stanley on Steel Dynamics (STLD): expect shares to underperform today following weak guidance

UBS Reiterates Buy Rating on NVIDIA (NVDA)

UBS Reiterates Buy Rating on Accenture plc (ACN)

UBS Reiterates Buy Rating on Aptiv PLC. (APTV), Highlights Positive Risk/Reward

Restoration Hardware (RH) PT Lowered to $160 at UBS

Morgan Stanley on Bicycle Therapeutics (BCYC): program deprioritization 'disappointing,' but 'right call'

Structure Therapeutics (GPCR) PT Raised to $145 at BMO Capital

BMO Capital Reiterates Underperform Rating on Dollar Tree (DLTR)

Dollar Tree (DLTR) PT Raised to $89 at BofA Securities

Zenas Biopharma (ZBIO) PT Raised to $55 at Guggenheim

Wolfe Research: Otis Worldwide (OTIS) should avoid bidding war for TK Elevator

Telos Corp. (TLS) PT Lowered to $5 at BMO Capital despite 'solid quarter' driven by Telos ID performance

Jefferies maintains Hold on Southwest Airlines (LUV) following major route cuts; United Airlines poised to gain market share

Oppenheimer reiterates Outperform on Relay Therapeutics (RLAY) as zovegalisib shows 11.1-month PFS

Raymond James looks for further durability in BMY's (BMY) MountainTAP-30 trial